Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease

Br J Haematol. 2013 Mar;160(5):709-10. doi: 10.1111/bjh.12146. Epub 2012 Dec 4.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Aged
  • Female
  • Humans
  • Interleukin-33
  • Interleukins / blood
  • Interleukins / deficiency*
  • Interleukins / physiology
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / etiology
  • Male
  • Middle Aged
  • Monoclonal Gammopathy of Undetermined Significance / blood
  • Multiple Myeloma / blood*
  • Multiple Myeloma / complications
  • Multiple Myeloma / immunology
  • Multiple Myeloma / pathology
  • Myeloma Proteins / analysis
  • Neoplasm Staging
  • Osteolysis / blood
  • Osteolysis / etiology

Substances

  • IL33 protein, human
  • Interleukin-33
  • Interleukins
  • Myeloma Proteins